Brief: Scope Fluidics Says Bacteromic Project Gets Validation Under First Preregistration Tests
30/09/2021 17:52
Sept 30 (Reuters) - Scope Fluidics SA SCPP.WA :
* BACTEROMIC PROJECT GETS VALIDATION UNDER FIRST
PREREGISTRATION
TESTS
* RESULTS GIVE BASIS FOR APPLYING TO POLAND'S MEDICINE
AUTHORITY
FOR REGISTERING BACTEROMIC AS MEDICAL PRODUCT FOR IN VITRO
DIAGNOSTICS
* COMPANY WILL BE CONTINUE FURTHER RESEARCH AND DEVELOPMENT
FOR
BACTEROMIC
Source text for Eikon: ID:nEM7zS0sRa
Further company coverage: SCPP.WA
(Reporting by Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com;))
Recent news on Scope Fluidics SA
See all newsBrief: Scope Fluidics Extends Deadline For First Milestone Of Hybolic Project To End Of Q3 2026
Brief: Scope Fluidics Says Bacteromic Granted U.S. Patent 'Microfluidic Chip'
Brief: Scope Fluidics Q1 Net Loss At 13.5 Million Zlotys
Brief: Scope Fluidics Unit Bacteromic Starts Collaboration With US Research Center For FDA Registration Trials
Brief: Scope Fluidics FY Net Loss At 46.4 Million Zlotys